1. 1. Sung H, Ferlay J, Siegel RL, et al. (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal For Clinicians, 71(3): 209-249. [DOI:10.3322/caac.21660] [PMID]

2. Chen W, Sun K, Zheng R, et al. (2018) Cancer incidence and mortality in China, 2014. Chin J Cancer Res, 30(1): 1-12. [DOI:10.21147/j.issn.1000-9604.2018.01.01] [PMID] []

3. Van Cutsem E, Sagaert X, Topal B, et al. (2016) Gastric cancer. Lancet, 388(10060): 2654-26564. [DOI:10.1016/S0140-6736(16)30354-3]

4. Smyth EC, Nilsson M, Grabsch HI, et al. (2020) Gastric cancer. Lancet (London, England), 396(10251): 635-648. [DOI:10.1016/S0140-6736(20)31288-5]

5. Ajani JA, D'Amico TA, Bentrem DJ, et al. (2022) Gastric cancer, Version 2.2022, NCCN Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 20(2): 167-192.

6. Yu X, Zhang R, Cao S, et al. (2022) Observation of the effectiveness and safety of the combination of chemotherapy and radiotherapy after the radical resection of progressive gastric cancer. International Journal of Radiation Research, 20(1): 109-114. [DOI:10.52547/ijrr.20.1.17]

7. Zhao TT, Xu H, Xu HM, et al. (2018) The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials. Gastric cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 21(3): 361-371. [DOI:10.1007/s10120-018-0813-2] [PMID]

8. Patel TH and Cecchini M (2020) Targeted therapies in advanced gastric cancer. Current Treatment Options in Oncology, 21(9): 70. [DOI:10.1007/s11940-020-0616-8] [PMID]

9. (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513(7517): 202-209. [DOI:10.1038/nature13480] [PMID] []

10. Salem ME, Puccini A, Xiu J, et al. (2018) Comparative molecular analyses of esophageal squamous cell carcinoma, esophageal adenocarcinoma and gastric adenocarcinoma. The Oncologist, 23(11): 1319-1327. [DOI:10.1634/theoncologist.2018-0143] [PMID] []

11. Martínez VG, Moestrup SK, Holmskov U, et al. (2011) The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacological Reviews, 63(4): 967-1000. [DOI:10.1124/pr.111.004523] [PMID]

12. Yang S (2007) Gene amplifications at chromosome 7 of the human gastric cancer genome. Int J Mol Med, 20(2): 225-231. [DOI:10.3892/ijmm.20.2.225]

13. Gagliardi A, Porter VL, Zong Z, et al. (2020) Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. Nat Genet, 52(8): 800-810. [DOI:10.1038/s41588-020-0673-7] [PMID] []

14. Sun NK, Huang SL, Chang PY, et al. (2014) Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response. Oncotarget, 5(23): 11939-11956. [DOI:10.18632/oncotarget.2654] [PMID] []

15. to E, Honma R, Imai J, et al. (2003) A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor. Am J Pathol, 163(6): 2165-2172. [DOI:10.1016/S0002-9440(10)63573-0] [PMID]

16. Du Z, Xia Q, Wu B, et al. (2019) The analyses of SRCR genes based on protein-protein interaction network in esophageal squamous cell carcinoma. Am J Transl Res, 11(5): 2683-2705.

17. Li JH, Liu S, Zhou H, et al. (2014) StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Research, 42(Database issue): D92-97. [DOI:10.1093/nar/gkt1248] [PMID] []

18. Szász AM, Lánczky A, Nagy Á, et al. (2016) Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget, 7(31): 49322-49333. [DOI:10.18632/oncotarget.10337] [PMID] []

19. Tang Z, Li C, Kang B, et al. (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research, 45(W1): W98-w102. [DOI:10.1093/nar/gkx247] [PMID] []

20. Bu D, Luo H, Huo P, et al. (2021) KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis. Nucleic Acids Research, 49(W1): W317-w325. [DOI:10.1093/nar/gkab447] [PMID] []

21. Liu H, Wu N, Zhang Z, et al. (2019) Long Non-coding RNA LINC00941 as a potential biomarker promotes the proliferation and metastasis of gastric cancer. Frontiers in Genetics, 10: 5. [DOI:10.3389/fgene.2019.00005] [PMID] []

22. Liu H, Zhang Z, Wu N, et al. (2018) Integrative analysis of dysregulated incRNA-associated ceRNA network reveals functional incRNAs in gastric cancer. Genes (Basel), 9(6). [DOI:10.3390/genes9060303] [PMID] []

23. Fu M, Huang Z, Zang X, et al. (2018) Long noncoding RNA LINC00978 promotes cancer growth and acts as a diagnostic biomarker in gastric cancer. Cell Prolif, 51(1). [DOI:10.1111/cpr.12425] [PMID] []

24. Grelet S, Link LA, Howley B, et al. (2017) A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat Cell Biol, 19(9): 1105-1115. [DOI:10.1038/ncb3595] [PMID] []

25. Xu Q, Deng F, Qin Y, et al. (2016) Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis. Cell Death Dis, 7(6): e2254. [DOI:10.1038/cddis.2016.149] [PMID] []

26. Lordick F, Carneiro F, Cascinu S, et al. (2022) Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 33(10): 1005-1020. [DOI:10.1016/j.annonc.2022.07.004] [PMID]

27. Röcken C (2023) Predictive biomarkers in gastric cancer. Journal of Cancer Research and Clinical Oncology, 149(1): 467-481. [DOI:10.1007/s00432-022-04408-0] [PMID] []

28. Guan WL, He Y, Xu RH (2023) Gastric cancer treatment: Recent progress and future perspectives. Journal of Hematology and Oncology, 16(1): 57. [DOI:10.1186/s13045-023-01451-3] [PMID] []

29. Leiserson MD, Wu HT, Vandin F, et al. (2015) CoMEt: A statistical approach to identify combinations of mutually exclusive alterations in cancer. Genome Biol, 16(1): 160. https://doi.org/10.1186/s13059-015-0700-7 [DOI:10.1007/978-3-319-16706-0_19] [PMID] []

30. Xie W, Chen C, Han Z, et al. (2020) CD2AP inhibits metastasis in gastric cancer by promoting cellular adhesion and cytoskeleton assembly. Molecular Carcinogenesis, 59(4): 339-352. [DOI:10.1002/mc.23158] [PMID] []

31. Dong C, Wu Y, Yao J, et al. (2012) G9a interacts with snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest, 122(4): 1469-1486. [DOI:10.1172/JCI57349] [PMID] []

32. Park J and Schwarzbauer JE (2014) Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition. Oncogene, 33(13): 1649-1657. [DOI:10.1038/onc.2013.118] [PMID] []